U.S. Department of Energy
http://www.energy.gov
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From U.S. Department of Energy
Hopes For Disease Modification In Huntington’s Disease
A group at the Lawrence Berkeley National Laboratory believes that a synthetic antioxidant previously shown to reduce apoptosis and enhance cell survival in vitro can ameliorate the symptoms of Huntington’s Disease – and beyond its neuroprotective effects, may even have disease modifying properties. They’ve published the first proof of concept in animals, aiming to bring the compound into human studies.
Deals Update (01/2008)
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Recent Tech Transfer Deals (01/08)
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
Company Information
- Industry
- Academic and Research Institutions
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice